Key Highlights
- Texas Instruments exceeded first quarter 2026 expectations, reporting EPS of $1.68 compared to the $1.36 consensus estimate
- The company posted $4.83 billion in revenue, surpassing the anticipated $4.52 billion
- The Industrial division expanded over 20% from the previous quarter; Data Center operations jumped more than 25%
- Barclays elevated TXN to Equalweight with a revised price target increasing from $175 to $250
- Several Wall Street firms increased their price objectives, with KeyBanc reaching $325 and Rosenblatt hitting $330
Texas Instruments delivered an impressive opening quarter for 2026, comfortably surpassing Wall Street projections across both profit and sales metrics. Earnings per share reached $1.68, significantly outpacing the $1.36 analyst consensus. The company’s revenue totaled $4.83 billion compared to forecasts of $4.52 billion.
Shares climbed approximately 16% following the announcement, rising from roughly $233 to trade around $274.
Texas Instruments Incorporated, TXN
The impressive performance stemmed from robust activity in two critical business segments: Industrial and Data Center. The Industrial division posted sequential growth exceeding 20% in March quarter results. Meanwhile, Data Center operations expanded by more than 25% during the identical timeframe.
Second quarter projections arrived modestly ahead of typical seasonal patterns, suggesting sustained momentum in these two divisions. However, Automotive sector demand continued to show volatility, as noted by UBS.
Wall Street Responds with Upgrades and Higher Targets
Barclays executed the most significant adjustment, elevating TXN from Underweight to Equalweight while increasing its price objective from $175 to $250. The investment bank attributed the revision to strengthening fundamentals in Industrial and Data Center markets.
Barclays projects Data Center revenue will surge over 90% throughout calendar year 2026. The firm also anticipates Industrial performance will again exceed seasonal expectations in the June quarter.
The bank now forecasts $10 per share in free cash flow for TXN during calendar year 2027. This projection exceeds the current Wall Street consensus of approximately $8.55.
UBS maintained its Buy recommendation while elevating its target from $260 to $295. The firm indicated results aligned with heightened expectations, while forward guidance provided a modest upside surprise.
Cantor Fitzgerald increased its objective from $250 to $280 while maintaining a Neutral stance. The firm applied an enhanced 28x valuation multiple versus the prior 25x, acknowledging improving dynamics in analog semiconductor markets.
Additional Analyst Commentary
KeyBanc established the highest price target, raising it to $325. BofA Securities upgraded TXN to Buy with a $320 objective, highlighting momentum in aerospace and defense applications within the industrial segment.
Rosenblatt lifted its target to $330. Baird increased to $300. Wolfe Research, which observed Q1 revenue climbing 9% sequentially, established a $315 target.
TXN currently commands a valuation of approximately 26 times free cash flow, elevated compared to its historical mid-teens multiple. The stock’s price-to-earnings ratio stands at 43.15.
Barclays cautioned that the company faces execution challenges regarding consensus estimates for the year’s latter half. Cantor Fitzgerald similarly highlighted concerns around memory supply limitations and geopolitical uncertainties as factors warranting selectivity within the broader semiconductor sector.
The stock was changing hands near $274, approaching its previous 52-week peak of $238.80 established before the earnings-driven rally.
